ROYAL BANK OF CANADA - SUNESIS PHARMACEUTICALS INC ownership

SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 52 filers reported holding SUNESIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SUNESIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$1,0000.0%2,587
+1.3%
0.00%
Q1 2020$1,0000.0%2,554
+64.1%
0.00%
Q3 2019$1,0000.0%1,556
+86.8%
0.00%
Q2 2019$1,0000.0%833
-3.8%
0.00%
Q1 2019$1,000866
+4.0%
0.00%
Q4 2018$0
-100.0%
833
-8.6%
0.00%
Q3 2018$2,0000.0%911
+9.4%
0.00%
Q2 2018$2,0000.0%8330.0%0.00%
Q1 2018$2,000
-33.3%
833
-1.2%
0.00%
Q4 2017$3,000843
+8330.0%
0.00%
Q3 2017$010
-90.0%
0.00%
Q4 2016$0
-100.0%
100
-62.5%
0.00%
Q3 2016$1,0002670.00%
Other shareholders

There were no reported owners of SUNESIS PHARMACEUTICALS INC in Q3 2018.

NameSharesValueWeighting ↓
View complete list of SUNESIS PHARMACEUTICALS INC shareholders